Epilepsy, a chronic neurological condition, can potentially allow up to 70% of individuals to live seizure-free with appropriate diagnosis and treatment, but it also carries a threefold higher risk of premature death compared to the general population, underscoring its seriousness. Epilepsy is a chronic neurological condition characterized by recurrent seizures and disturbances in consciousness. It can be correlated with the Ayurvedic concept of Apasmara, which involves occasional unconsciousness accompanied by unpleasant symptoms such as vomiting froth and abnormal body postures. Ayurveda recognizes Ghrita (ghee), particularly Go Ghrita derived from cow's milk, as a versatile food and medicinal substance with therapeutic effects. Go Ghrita is highly regarded for its ability to balance Vata and Pitta Doshas and its lipophilic nature, allowing it to penetrate the blood-brain barrier for targeted delivery and increased bio-availability. Go Ghrita's Rasayana property suggests that long-term use may help reduce the recurrence of epilepsy. When medications are processed with Ghrita, it enhances their medicinal properties, making formulations utilizing Go Ghrita potentially more advantageous and efficacious for treating epilepsy.
Diabetes Mellitus (DM) is one among the most common lifestyle related disorders in the present era. In type II DM, prevalence of microalbuminuria is 20 -25% in both newly diagnosed and established cases. Microalbuminuria defined as urinary albumin excretion of 30 -300 mg/day is an earlier sign of vascular damage due to complications of DM and a marker of general vascular dysfunction. Microalbuminuria is seen in the third stage of diabetic nephropathy and is a leading cause of End Stage Renal Disorder (ESRD). In Ayurveda, Lakshanas (symptoms) of Kaphapittavruta Madhumeha (DM with Kapha and Pitta obstruction) show similarity to the features of microalbuminuria. Aragwadhaadigana Kashaya( Medicated Decoction) having Kaphapittasamana (reduces Kapha and Pitta humours), Pramehahara, Apatarpana(non nourishing) properties is considered to be effective in Prameha(Obstinate urinary disorders including Diabetes) associated with Kapha Pitta Aavarana (Obstruction). A 60-year-old male patient, already a known case of DM for the past 20 years came to our OPD with complaints of frothiness of urine, urgency of micturition and bilateral ankle swelling for one year along with generalized tiredness for two years. On investigation, 24-hour urine microalbumin was found to be 281 mg/day. The patient was advised to take Aragwadhadigana Kashaya 48 ml twice daily for 30 days. At the end of the study, significant changes in subjective criteria and 24hour urine microalbumin were observed. This effective treatment protocol can prove as a noninvasive safe therapy in managing Microalbuminuria in Type II Diabetes Mellitus.
Dyspepsia is a common complaint among individuals seeking medical care as well as in general population. Non-Ulcer Dyspepsia (NUD) also known as Functional Dyspepsia (FD) occupies a larger space. Prevalence of NUD is about 20-30% worldwide. In India, about 7.6% to 49% of Indian population report NUD symptoms annually. Ayurveda vividly describes Gastro-Intestinal (GI) diseases in the context of Amlapitta (NUD). The aim of this study is to evaluate the effectiveness of Nisthusha (dehusked) Yavaadi Kashaya (Medicated decoction) in the management of Amlapitta (NUD). A 21 -years old male patient, visited the Kayachikitsa OPD, Pankajakasthuri Ayurveda Hospital, Kattakkada, Thiruvananthapuam on 28-05-2018, with the complaints of Post-Prandial Fullness, Early satiety and Epi-gastric pain with general weakness of the body for 4 months. Irregular dietary habits, untimely food intake, outside food-stuffs of him lead to this condition. The patient was advised to take 48ml of Nisthusha(dehusked) yavaadi Kashaya (Medicated decoction) in BD dose before food, with Trijataka (Twak, Ela, Patra) Choorna (Powder) 1g as prakshepaka dravya (adjuvant sprinkled over the medicated decoction which is to be consumed) followed by Mudga (Green Gram) Yusha (Soup preparation) 48ml dose as BD as Anupana (Adjuvant) for 15 days. Assessments were done on the 0 th , 15 th , & 30 th day where, marked changes were noted subjectively through the grading scale. This effective treatment proved to be a non-invasive safe therapy in the management of Amlapitta (NUD).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.